AltheaDx Files For IPO

San Diego-based biotech developer AltheaDx has filed for an IPO, saying that it is looking to raised up to $69.0M in an IPO on the NASDAQ Global Market. The company said it has applied to trade under the symbol IDGX. The IPO is being underwritten by Citigroup, Jeffries, William Blair, and Cantor Fitzgerald & Co. AlteaDx is developing molecular diagnostics technology for personalized medicine. AltheaDx is venture backed by Telegraph Hill Partners and Alma Life Sciences.